Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.
Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.
Discover more about S&P Global’s offerings
Iovance Biotherapeutics names CFO
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Iovance Biotherapeutics Inc. appointed Timothy Morris to be CFO, effective Aug. 14.
Morris most recently served as CFO and head of business development of AcelRx Pharmaceuticals Inc.